Halyard Health Inc. (HYH) Downgraded by Zacks Investment Research to Sell
According to Zacks, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. “
HYH has been the subject of several other reports. Deutsche Bank AG raised their price objective on shares of Halyard Health from $36.00 to $41.00 and gave the stock a buy rating in a report on Wednesday, August 10th. TheStreet upgraded shares of Halyard Health from a sell rating to a hold rating in a research note on Friday, July 8th. Finally, Stifel Nicolaus increased their target price on shares of Halyard Health from $32.00 to $37.00 and gave the stock a buy rating in a research note on Tuesday, June 14th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the stock. Halyard Health presently has a consensus rating of Hold and a consensus target price of $34.20.
Halyard Health (NYSE:HYH) opened at 33.99 on Tuesday. The stock’s market cap is $1.59 billion. Halyard Health has a 52 week low of $22.76 and a 52 week high of $37.31. The firm has a 50-day moving average price of $35.11 and a 200-day moving average price of $32.79.
Halyard Health (NYSE:HYH) last released its quarterly earnings data on Wednesday, August 3rd. The company reported $0.45 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.36 by $0.09. The company earned $400 million during the quarter, compared to the consensus estimate of $383.08 million. Halyard Health had a negative net margin of 27.63% and a positive return on equity of 8.91%. Halyard Health’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period last year, the firm earned $0.52 EPS. On average, equities research analysts predict that Halyard Health will post $1.82 EPS for the current year.
Hedge funds have recently bought and sold shares of the company. IFP Advisors Inc boosted its stake in Halyard Health by 1.9% in the second quarter. IFP Advisors Inc now owns 3,141 shares of the company’s stock valued at $102,000 after buying an additional 58 shares in the last quarter. Tower Research Capital LLC TRC purchased a new stake in Halyard Health during the second quarter valued at about $104,000. LS Investment Advisors LLC boosted its stake in Halyard Health by 25.6% in the second quarter. LS Investment Advisors LLC now owns 3,241 shares of the company’s stock valued at $105,000 after buying an additional 661 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new stake in Halyard Health during the second quarter valued at about $109,000. Finally, Point72 Asset Management L.P. purchased a new stake in Halyard Health during the second quarter valued at about $182,000. Institutional investors and hedge funds own 82.93% of the company’s stock.
About Halyard Health
Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.